欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/H/0100/002
药品名称Lorista 12,5
活性成分
    • Losartan potassium salt 12.5 mg
剂型Film-coated tablet
上市许可持有人KRKA d.d. Šmarješka cesta 6, 8501 Novo mesto Slovenia
参考成员国 - 产品名称Czechia (CZ)
互认成员国 - 产品名称
    • Italy (IT)
    • Norway (NO)
    • Finland (FI)
    • Lithuania (LT)
      Lorista 12,5 mg plėvele dengtos tabletės
    • France (FR)
    • Austria (AT)
      Losartan Krka 12,5 mg Filmtabletten
    • United Kingdom (Northern Ireland) (XI)
    • Belgium (BE)
    • Denmark (DK)
    • Germany (DE)
    • Spain (ES)
    • Cyprus (CY)
    • Latvia (LV)
    • Iceland (IS)
    • Hungary (HU)
    • Bulgaria (BG)
      Lorista
    • Sweden (SE)
许可日期2007/03/12
最近更新日期2024/10/30
药物ATC编码
    • C09CA01 losartan
申请类型
  • TypeLevel1:Line Extension
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase